On April 17, 2017, Adamas Pharmaceuticals, Inc. entered into an offer letter with Richard A. King pursuant to which Mr. King will become Adamas' Chief Operating Officer, effective April 28, 2017. Mr. King, age 52, has held executive leadership roles at numerous companies in the life sciences industry throughout his career. Most recently, from May 2016 to April 2017, Mr. King was Chief Operating Officer at The Scripps Research Institute, where he was responsible for strategic planning, business development, finance, human resources, facilities, information technology and research services.